Compound Detail
CHEMBL281872
ZD-4190 FREE BASE Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL281872 |
| Name | ZD-4190 FREE BASE |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | YBTGTVGEKMZEQX-UHFFFAOYSA-N |
6
Targets
10
Activities
1
Assay Types
5
PK Parameters
20
Publications
0
Known Names
Molecular Properties
459.3
MW (Da)
3.95
ALogP
8
HBA
1
HBD
87.0
PSA (Ų)
0.45
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Activity Summary
IC50 10 meas. best 7.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.52 | 7.52 | 30.0 | 2 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 7.3 | 6.85 | 50.0 | 2 |
| Vascular endothelial growth factor receptor CHEMBL2095227 | IC50 | 7.3 | 7.3 | 50.0 | 2 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 6.16 | 6.16 | 700.0 | 2 |
| Fibroblast growth factor receptor CHEMBL2095217 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 5.47 | 5.47 | 3400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.333 | mL.min-1.kg-1 | Canis lupus familiaris |
| F | 80.0 | % | Rattus norvegicus |
| F | 5.0 | % | Canis lupus familiaris |
| T1/2 | 1.3 | hr | Rattus norvegicus |
| T1/2 | 1.1 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11881999 | 10.1021/jm011022e | No relevant target | 4 |
| 11881999 | 10.1021/jm011022e | Rattus norvegicus | 3 |
| 11881999 | 10.1021/jm011022e | Canis familiaris | 3 |
| 10639280 | 10.1021/jm990345w | Mus musculus | 2 |
| 11881999 | 10.1021/jm011022e | Epidermal growth factor receptor | 2 |
| 11881999 | 10.1021/jm011022e | ADMET | 2 |
| 11881999 | 10.1021/jm011022e | Angiopoietin-1 receptor | 1 |
| 10639280 | 10.1021/jm990345w | HUVEC | 1 |
| 11881999 | 10.1021/jm011022e | Mus musculus | 1 |
| 11881999 | 10.1021/jm011022e | 3-phosphoinositide-dependent protein kinase 1 | 1 |
| 11881999 | 10.1021/jm011022e | Serine/threonine-protein kinase AKT | 1 |
| 11881999 | 10.1021/jm011022e | Insulin-like growth factor 1 receptor | 1 |
| 11881999 | 10.1021/jm011022e | Cyclin-dependent kinase 2 | 1 |
| 11881999 | 10.1021/jm011022e | Dual specificity mitogen-activated protein kinase kinase; MEK1/2 | 1 |
| 11881999 | 10.1021/jm011022e | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 11881999 | 10.1021/jm011022e | Platelet-derived growth factor receptor beta | 1 |
| 11881999 | 10.1021/jm011022e | Vascular endothelial growth factor receptor 1 | 1 |
| 11881999 | 10.1021/jm011022e | HUVEC | 1 |
| 11881999 | 10.1021/jm011022e | Vascular endothelial growth factor receptor | 1 |
| 11881999 | 10.1021/jm011022e | Fibroblast growth factor receptor 1 | 1 |
Data from ChEMBL 36 via Core Engine